Martin Babler

Overview

Martin Babler received an average of $3M in total compensation, including $459K in salary, at Principia Biopharma from 2017 to 2019.

20172018201901.5M3M4.5M6M
Source: SEC filings on April 24, 2020 and April 26, 2019.

Related executives

We found three more executives who work or worked at Principia Biopharma.

David Goldstein

Principia Biopharma

Chief Scientific Officer

Dolca Thomas

Principia Biopharma

Chief Medical Officer

Stefani Wolff

Principia Biopharma

Chief Development Officer

News

You may also like

0